Literature DB >> 138093

Decreased GABA and glutamate concentration in rat brain after treatment with 6-aminonicotinamide.

L Bielicki, J Krieglstein.   

Abstract

The effect of 6-aminonicotinamide (6-AN) on putative amino acid neurotransmitters, namely glutamate, GABA and aspartate was studied on brains of rats treated with this antimetabolite (35 mg/kg i.p.). After 6-AN application the following substrates and metabolites were determined: phosphocreatine, ATP, ADP, AMP, glucose, glucose 6-phosphate, fructose, glutamate, GABA, aspartate, ammonia, and 6-phosphogluconate. The alterations in the cerebral energy metabolism were found as reported in the literature (increased levels of glucose, glucose 6-phosphate, decreased levels of lactate and pyruvate) and could be interpreted as the result of a reduced glycolytic flux rate. After a prolonged period of 6-AN pretreatment (16-30 h) the GABA and glutamate concentrations were significantly reduced, whereas the level of aspartate remained unchanged. From the result presented the two following conclusions may be drawn: a) The changes in the concentration of neurotransmitters as GABA and glutamate could be responsible for some neurological symptoms produced by 6-AN. b) As 6-AN seems to affect the GABA-shunt it represents a model substance for studying this pathway in the nervous system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 138093     DOI: 10.1007/bf00507848

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  16 in total

1.  Inhibition of NADP dependent oxidoreductases by the 6-aminonicotinamide analogue of NADP.

Authors:  E Köhler; H -J. Barrach; D Neubert
Journal:  FEBS Lett       Date:  1970-02-16       Impact factor: 4.124

2.  6-Aminonicotinamide and acute degenerative changes in the central nervous system.

Authors:  S S STERNBERG; F S PHILIPS
Journal:  Science       Date:  1958-03-21       Impact factor: 47.728

3.  6-Aminonicotinamide--a Potent Nicotinamide Antagonist.

Authors:  W J Johnson; J D McColl
Journal:  Science       Date:  1955-10-28       Impact factor: 47.728

4.  [Morphological findings in the central nervous system of the rat after poisoning with antimetabolites of nicotinamide (6-aminonicotinamide and 3-acetylpyridine) and a quinoline derivative (5-nitro-8-hydroxyquinoline)].

Authors:  H Schneider; H Coper
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1968-08-22

5.  Blocking of pentose phosphate pathway in the brain of rats by 6-aminonicotinamide.

Authors:  H Herken; K Lange
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

6.  Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods.

Authors:  L T Graham; M H Aprison
Journal:  Anal Biochem       Date:  1966-06       Impact factor: 3.365

7.  [Experimental myelopathy--biochemical basis of its cellular pathogenesis (author's transl)].

Authors:  H Herken; K Keller; H Kolbe; K Lange; H Schneider
Journal:  Klin Wochenschr       Date:  1973-07-01

8.  [Brain carbohydrate metabolism following blockade of the pentose phosphate pathway by 6-aminonicotinamide].

Authors:  K Lange; H Kolbe; K Keller; H Herken
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1970-10

9.  Decreased glycolytic flux rate in the isolated perfused rat brain after pretreatment with 6-aminonicotinamide.

Authors:  J Krieglstein; R Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

10.  [BIOSYNTHESIS AND EFFECT OF 6-AMINONICOTINAMIDE-ADENINE DINUCLEOTIDE (6-ANAD)].

Authors:  A BRUNNEMANN; H COPER; D NEUBERT
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-02-13
View more
  6 in total

1.  Phenobarbital and 6-aminonicotinamide effect on cerebral enzymatic activities related to energy metabolism in different rat brain areas.

Authors:  F Marzatico; F Dagani; D Curti; G Benzi
Journal:  Neurochem Res       Date:  1987-01       Impact factor: 3.996

2.  The effect of 6-aminonicotinamide on the levels of brain amino acids and glucose, and their labeling with 14C after injection of [U-14C] glucose.

Authors:  M K Gaitonde; L P Lewis; G Evans; A Clapp
Journal:  Neurochem Res       Date:  1981-10       Impact factor: 3.996

3.  Decreased labeling of amino acids by inhibition of the utilization of [3H, 14C]glucose via the hexosemonophosphate shunt in rat brain in vivo.

Authors:  M K Gaitonde; M D James; G M Evans
Journal:  Neurochem Res       Date:  1984-03       Impact factor: 3.996

4.  Ultrastructure of 6-aminonicotinamide (6-AN)-induced lesions in the central nervous system of rats. II. Alterations of the nervous susceptibility with aging.

Authors:  N Horita; T Ishii; Y Izumiyama
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

5.  Long-lasting changes in regional brain amino acids and monoamines in recovered pyrithiamine treated rats.

Authors:  P J Langlais; R G Mair; C D Anderson; W J McEntee
Journal:  Neurochem Res       Date:  1988-12       Impact factor: 3.996

6.  The effect of inhibition of hexosemonophosphate shunt on the metabolism of glucose and function in rat brain in vivo.

Authors:  M K Gaitonde; G M Evans
Journal:  Neurochem Res       Date:  1982-09       Impact factor: 3.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.